Li Wen, Chen Bi-Feng
Editorial Department of Journal of Clinical Surgery, Hubei Medical Association, Wuhan, 430071, China.
School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
J Huazhong Univ Sci Technolog Med Sci. 2013 Dec;33(6):798-804. doi: 10.1007/s11596-013-1201-0. Epub 2013 Dec 13.
DNA methylation, one of the best-characterized epigenetic modifications, plays essential roles in diseases, including human cancers. In recent years, our understanding on DNA methylation with human cancers has made significant progress, which was facilitated by stunning development in the analysis of the human methylome of multiple cancer types. In this review, recent developments in the characterization of aberrant DNA methylation involved in human cancers development were discussed with special emphasis on the mechanisms of aberrant DNA methylation in human cancers. We also summarize the recent treatment strategy for human cancers with de-methylation drugs.
DNA甲基化是特征最明确的表观遗传修饰之一,在包括人类癌症在内的疾病中发挥着重要作用。近年来,我们对人类癌症中DNA甲基化的认识取得了重大进展,这得益于多种癌症类型人类甲基化组分析的惊人发展。在这篇综述中,我们讨论了人类癌症发生过程中异常DNA甲基化特征的最新进展,特别强调了人类癌症中异常DNA甲基化的机制。我们还总结了最近使用去甲基化药物治疗人类癌症的策略。